Skip to content
★ Sign in to follow
CB

Christian Behrenbruch

CEO
Chief Executive Officer
Telix Pharmaceuticals Ltd
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€426k
▼ Sales (0 ops.)
—

Latest filing published 06 May 2026 for Telix Pharmaceuticals Ltd, €426k.

Filing timeline

BuySale
Christian Behrenbruch

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Christian Behrenbruch: trading record in brief

One trade, one date: on 6 May 2026, Christian Behrenbruch disclosed an open-market purchase of €426k in Telix Pharmaceuticals Ltd. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Christian Behrenbruch

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    MD & Group CEOExecutivesTelix Pharmaceuticals Ltd
    499,560 USD30SEC
    34,500 shares@ US$14.480.013% mcap100.0% of flowOrdinary SharesSEC:0001628280-26-031608:0
    Canonical exit: 27 Jul 2026 (T+90)

1 of 1 declaration